AzTrials
AzTrials

Metabolic DiseasesHIIT-HeartNCT02738385

Intensity Training and Cardiovascular Health in Colombian Adults

A study testing High Intensity Interval Training and Moderate Intensity Interval Training in people with Metabolic Diseases, run by Universidad Santo Tomas at 1 site in Colombia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Several studies have shown relationship between exercise intensity and improvement cardiometabolic health. It has been suggested that high intensity interval training and also moderate training generate positive effects on metabolic risk factors. Read more about this study

Who is it for?
Ages 20 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Metabolic Diseases
What is being tested?
High Intensity Interval Training and Moderate Intensity Interval Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteColombia
Study dates
Jun 2015to Oct 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Written informed consent.
  • Interested in improving health and fitness.

Who cannot join

  • Systemic infections.
  • Weight loss or gain of >10% of body weight in the past 6 months for any reason.
  • Currently taking medication that suppresses or stimulates appetite.
  • Uncontrolled hypertension: systolic blood pressure 160 mm Hg or diastolic blood pressure 95 mm Hg on treatment.
  • Gastrointestinal disease, including self-reported chronic hepatitis or cirrhosis, any episode of alcoholic hepatitis or alcoholic pancreatitis within past year inflammatory bowel disease requiring treatment in the past year, recent or significant abdominal surgery (e.g., gastrectomy).
  • Asthma.
Show all 12Show fewer
  • Diagnosed diabetes (type 1 or 2), fasting impaired glucose tolerance (blood glucose 118 mg/dL), or use of any anti-diabetic medications.
  • Currently taking antidepressant, steroid, or thyroid medication, unless dosage is stable (no change for 6 months).
  • Any active use of illegal or illicit drugs.
  • Current exerciser (>30 min organized exercise per week).
  • Indication of unsuitability of current health for exercise protocol (PARQ).
  • Any other conditions which, in opinion of the investigators, would adversely affect the conduct of the trial.

Trial locations and contacts

1 site in 1 country.

Colombia1 site
  • Robinson Ramírez Vélez Ph.D

    Bogotá

Other trials in Colombia

About this study

Official title: High Intensity Interval- vs Moderate Training on Biomarkers of Endothelial and Cardiovascular Health in Adults: Effect of Postprandial Period

Several studies have shown relationship between exercise intensity and improvement cardiometabolic health. It has been suggested that high intensity interval training and also moderate training generate positive effects on metabolic risk factors. For these reasons, it is necessary to clarify which type of training, is more effective to improve cardiometabolic health in latinamerican population.

Being tested
High Intensity Interval Training, Moderate Intensity Interval Training
Medical subject headings
Metabolic Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High Intensity Interval TrainingBehavioural

    Exercise will be performed at three sessions per week. All sessions will be supervised by a trained health or exercise professional.

  • Moderate Intensity Interval TrainingBehavioural

    Exercise will be performed at three sessions per week. All sessions will be supervised by a trained health or exercise professional.

Study groups in NCT02738385
Study groupRoleWhat they receive
High Intensity Interval TrainingExperimentalWalking on a treadmill 4min at 80-90% peak heart rate and recovery 4 min at 65% peak heart rate until expenditure of 300 kcal until the end of training.
Receives: Behavioral: High Intensity Interval Training
Moderate Intensity Interval TrainingActive comparatorWalking on a treadmill at 60-80% peak heart rate until expenditure of 300 kcal until the end of training.
Receives: Behavioral: Moderate Intensity Interval Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline in endothelial function as measured by flow-mediated vasodilation (FMD)

    FMD will be measured using the guidelines reported by Corretti et al. The diameter of the brachial artery will be assessed using a high-resolution ultrasound device (Siemens SG-60, USA), equipped with a 7.5 MHz linear array transducer

    Measured: Baseline, 2 and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.

Secondary outcomes (14)
  1. Change from Baseline in LDL Cholesterol

    Measured: Baseline, 2 and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.

  2. Change from Baseline in HDL Cholesterol

    Measured: Baseline, 2 and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.

  3. Change from Baseline in Triglycerides

    Measured: Baseline, 2 and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.

  4. Change from Baseline in Glucose

    Measured: Baseline, 2 and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.

  5. Change from Baseline in Heart rate variability

    HRV will be performed according to current recommendations by European Society of Cardiology using an evaluated share-ware

    Measured: Baseline, 2 and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.

  6. Aortic pulse wave velocity (PWVao)

    PWVao (m s-1) will be performed within 3 to 4 minutes with the oscillometric, occlusive device, the Arteriograph. The measurement will be taken in a supine position and were accepted if the quality indicator of the recordings was within the acceptable range (i.e., if the standard deviation [SD] of the beat-to-beat measured PWVao values was less than 1.1 m/sec).

    Measured: Baseline, 2 and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.

  7. Change from Baseline in muscular fitness

    Muscular fitness (MF) will be assessed using handgrip test (maximum handgrip strength assessment) using a standard adjustable handle analogue handgrip dynamometer T-18 TKK SMEDLY III®

    Measured: Baseline, 2 and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.

  8. Change from Baseline in Flexibility using the sit and reach test

    It will be determined using a maximum treadmill exercise test (Precor TRM 885, Italy) following the modified Balke protocol

    Measured: Baseline, 2 and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.

  9. Change from Baseline in peak uptake of volume of oxygen

    Measured: Baseline, 2 and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.

  10. Change from Baseline in Blood Pressure

    Measured: Baseline, 2 and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.

  11. Change from Baseline in Body Mass Index

    BMI will be calculated as the body weight in kilograms divided by the square of the height in meters.

    Measured: Baseline, 2 and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.

  12. Change from Baseline in Body Mass

    Measured: Baseline, 2 and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.

  13. Change from Baseline in Quality & satisfaction with life by SF Community - short-form survey (SF-12™) Colombian version

    Measured: Baseline and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.

  14. Augmentation index (AIx)

    AIx (%) will be performed within 3 to 4 minutes with the oscillometric, occlusive device, the Arteriograph. The measurement will be taken in a supine position and were accepted if the quality indicator of the recordings was within the acceptable range (i.e., if the standard deviation [SD] of the beat-to-beat measured AIx values was less than 1.1 m/sec).

    Measured: Baseline, 2 and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Apr 2016 (estimated)
  2. Study startJun 2015
  3. Primary completionOct 2016
  4. Study completionOct 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02738385
Sponsor's protocol ID
01-1802-2013
Acronym
HIIT-Heart
Status last verified
Oct 2016
First submitted
23 Mar 2016
Last updated
25 Oct 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • Ramirez-Velez R, Hernandez-Quinones PA, Tordecilla-Sanders A, Alvarez C, Ramirez-Campillo R, Izquierdo M, Correa-Bautista JE, Garcia-Hermoso A, Garcia RG. Effectiveness of HIIT compared to moderate continuous training in improving vascular parameters in inactive adults. Lipids Health Dis. 2019 Feb 4;18(1):42. doi: 10.1186/s12944-019-0981-z.

    PubMed 30717757
  • Ramirez-Velez R, Correa-Rodriguez M, Tordecilla-Sanders A, Aya-Aldana V, Izquierdo M, Correa-Bautista JE, Alvarez C, Garcia-Hermoso A. Exercise and postprandial lipemia: effects on vascular health in inactive adults. Lipids Health Dis. 2018 Apr 3;17(1):69. doi: 10.1186/s12944-018-0719-3.

    PubMed 29615070
  • Ramirez-Velez R, Tordecilla-Sanders A, Tellez-T LA, Camelo-Prieto D, Hernandez-Quinonez PA, Correa-Bautista JE, Garcia-Hermoso A, Ramirez-Campillo R, Izquierdo M. Similar cardiometabolic effects of high- and moderate-intensity training among apparently healthy inactive adults: a randomized clinical trial. J Transl Med. 2017 May 30;15(1):118. doi: 10.1186/s12967-017-1216-6.

    PubMed 28558739
  • Ramirez-Velez R, Tordecilla-Sanders A, Tellez-T LA, Camelo-Prieto D, Hernandez-Quinonez PA, Correa-Bautista JE, Garcia-Hermoso A, Ramirez-Campillo R, Izquierdo M. Effect of Moderate- Versus High-Intensity Interval Exercise Training on Heart Rate Variability Parameters in Inactive Latin-American Adults: A Randomized Clinical Trial. J Strength Cond Res. 2020 Dec;34(12):3403-3415. doi: 10.1519/JSC.0000000000001833.

    PubMed 28198783

Questions about this trial

What is this clinical trial studying?

A study testing High Intensity Interval Training and Moderate Intensity Interval Training in people with Metabolic Diseases, run by Universidad Santo Tomas at 1 site in Colombia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Colombia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline in endothelial function as measured by flow-mediated vasodilation (FMD) (time frame: Baseline, 2 and 12 weeks immediately after the interventions ends, preceding an 'unhealthy' meal.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02738385, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Oct 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in